APA

Algotar A. M., Thompson P. A., Ranger-Moore J., Stratton M. S., Hsu C. H., Ahmann F. R., Nagle R. B. & Stratton S. P. (20131113). Differences in characteristics of men with localised prostate cancer who demonstrate low, intermediate or high prostate-specific antigen velocity. : Internal medicine journal.

Chicago

Algotar A M, Thompson P A, Ranger-Moore J, Stratton M S, Hsu C H, Ahmann F R, Nagle R B and Stratton S P. 20131113. Differences in characteristics of men with localised prostate cancer who demonstrate low, intermediate or high prostate-specific antigen velocity. : Internal medicine journal.

Harvard

Algotar A. M., Thompson P. A., Ranger-Moore J., Stratton M. S., Hsu C. H., Ahmann F. R., Nagle R. B. and Stratton S. P. (20131113). Differences in characteristics of men with localised prostate cancer who demonstrate low, intermediate or high prostate-specific antigen velocity. : Internal medicine journal.

MLA

Algotar A M, Thompson P A, Ranger-Moore J, Stratton M S, Hsu C H, Ahmann F R, Nagle R B and Stratton S P. Differences in characteristics of men with localised prostate cancer who demonstrate low, intermediate or high prostate-specific antigen velocity. : Internal medicine journal. 20131113.